James A. Wells
77Patents
37h-index
56Co-inventors
91Inventor score
Filing activity: May 29, 1984 → Apr 8, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5750373A | Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants | Emerging Cross-Sectional Technologies | 617 | Expired |
| US5821047A | Monovalent phage display | Emerging Cross-Sectional Technologies | 534 | Expired |
| US6884879B1 | Anti-VEGF antibodies | Chemistry; Metallurgy | 319 | Expired |
| US4760025A | Modified enzymes and methods for making same | Chemistry; Metallurgy | 235 | Expired |
| US5834250A | Method for identifying active domains and amino acid residues in polypeptides and hormone variants | Emerging Cross-Sectional Technologies | 206 | Expired |
| US7060269B1 | Anti-VEGF antibodies | Chemistry; Metallurgy | 159 | Expired |
| US5849535A | Human growth hormone variants | Emerging Cross-Sectional Technologies | 153 | Expired |
| US5534617A | Human growth hormone variants having greater affinity for human growth hormone receptor at site 1 | Emerging Cross-Sectional Technologies | 130 | Expired |
| US5580723A | Method for identifying active domains and amino acid residues in polypeptides and hormone variants | Emerging Cross-Sectional Technologies | 119 | Expired |
| USRE34606E | Modified enzymes and methods for making same | General | 101 | Expired |
| US6057292A | Method for inhibiting growth hormone action | Emerging Cross-Sectional Technologies | 101 | Expired |
| US5688666A | Growth hormone variants with altered binding properties | Physics | 101 | Expired |
| US5700676A | Modified subtilisins having amino acid alterations | Chemistry; Metallurgy | 99 | Expired |
| US6013478A | Method for identifying active domains and amino acid residues in polypeptides and hormone variants | Emerging Cross-Sectional Technologies | 95 | Expired |
| US7169901B2 | Anti-VEGF antibodies | Chemistry; Metallurgy | 94 | Expired |
| US5780279A | Method of selection of proteolytic cleavage sites by directed evolution and phagemid display | Chemistry; Metallurgy | 92 | Expired |
| US6451561B1 | Growth hormone variants | Emerging Cross-Sectional Technologies | 82 | Expired |
| US6428954B1 | Method for identifying active domains and amino acid residues in polypeptides and hormone variants | Emerging Cross-Sectional Technologies | 79 | Expired |
| US5506107A | Selecting ligand agonists and antagonists | Physics | 78 | Expired |
| US6271198A | Constrained helical peptides and methods of making same | Chemistry; Metallurgy | 74 | Expired |
| US7365166B2 | Anti-VEGF antibodies | Chemistry; Metallurgy | 73 | Active |
| US6013763A | Peptide variants of protein A | Emerging Cross-Sectional Technologies | 67 | Expired |
| US5834598A | Human growth hormone variants | Emerging Cross-Sectional Technologies | 65 | Expired |
| US6040136A | Enrichment method for variant proteins with altered binding properties | Emerging Cross-Sectional Technologies | 65 | Expired |
| US7297334B2 | Anti-vegf antibodies | Chemistry; Metallurgy | 62 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.